Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: A long-term randomized controlled trial

Journal of Chinese Integrative Medicine

Volumn 10, Issue 6, 2012, Pages 641-646

  Fu, Peng ^a   Huang, Xue Qiang ^b   Yuan, Ai Hong ^a   Yu, Guang ^b   Mei, Xiao Bin ^b   Cui, Ruo Lan ^b  

^a TONGJI UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Alprostadil; Chronic kidney disease; Randomized controlled trial; Reduced glutathione; Salvianolate

Indexed keywords

ALBUMIN; CREATININE; ELECTROLYTE; GLUTATHIONE; HEMOGLOBIN; PROSTAGLANDIN E1; SALVIANOLATE; UNCLASSIFIED DRUG; URINARY TRACT AGENT;

ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; LEUKOCYTE COUNT; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALPROSTADIL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; GLUTATHIONE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84863109688     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20120607     Document Type: Article

References (13)

1. Peng WP, Huang YZ, Huang DP. Clinical effects of Kaishi Injection combined with salvianolate injection in treating patients with chronic renal failure: a report of 29 cases. Hainan Yi Xue. 2010; 21(5): 33-34. Chinese source.
2. Fu P, Yu G, Huang XQ, Xu J, Mei XB, Wu H, Yuan WJ. Effect of integrated traditional Chinese and Western medicine therapy on progression of acute renal failure in patients with chronic renal insufficiency: a short-term clinical study. J Chin Integr Med. 2004; 2 (6): 429-431. Chinese with abstract in English. Chinese source
3. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72(3): 247-259.
4. Nakayama Y, Inoue T, Kohda Y, Inoue H, Izumi Y, Tomita K, Nonoguchi H. Long-term observation of renal function on combination therapy with prostaglandin and angiotensin-converting enzyme inhibitor for chronic kidney disease. Clin Nephrol. 2008; 69(6): 402-407.
5. Germain MJ, Cohen LM, Davison SN. Withholding and withdrawal from dialysis: what we know about how our patients die. Semin Dial. 2007; 20(3): 195-199.
6. Shen QF. Clinical nephrology of traditional Chinese medicine. Shanghai: Shanghai Scientific and Technical Publishers. 1998: 305-329. Chinese source.
7. Xu M, Wang YP, Sun WK, Xuan LJ, Xu YM. Effect of salvianolate on renal function and endogenous endothelin release in chronic renal failure rats. Zhongguo Yao Li Xue Yu Du Li Xue Za Zhi. 2001; 15 (1): 32-35. Chinese with abstract in English. Chinese source
8. Hu Y, Zha Y, Yan XY. Effect of salvianolate injection on plasma endothelin-1 and calcitonin gene related peptide levels in treating chronic renal failure. Guizhou Yi Yao. 2011; 35(6): 502-504. Chinese with abstract in English. Chinese source
9. Wu ZL. Function of reactive oxygen metabolites. In: Wang HY. Nephrology. 3rd ed. Beijing: People's Medical Publishing House. 2008: 761-769. Chinese source.
10. Keegan RF, Webb CB. Oxidative stress and neutrophil function in cats with chronic renal failure. J Vet Intern Med. 2010; 24(3): 514-519.
11. Wu CG, Wang L, Fang CQ, Gao J. Protective effect of reduced glutathione on mitochondria in the kidney of diabetic rats. Zhonghua Tang Niao Bing Za Zhi. 2009; 1(5): 355-358. Chinese with abstract in English. Chinese source
12. Ling Y, Hu SX. Effects of alprostadil on apoptosis induced by renal ischemia-reperfusion injury in rabbits. Zhonghua Shi Yan Wai Ke Za Zhi. 2011; 28(8): 1356-1358. Chinese source.
13. PGEi Study Group; Koch JA, Plum J, Grabensee B, Mödder U. Prostaglandin Ei: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? Nephrol Dial Transplant. 2000; 15 (1): 43-49.